Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana (IHS)
Multicenter Research Study to Build a Repository That Will Allow Researchers to Study Chronic Diseases in the Population of Central Indiana
연구 개요
상태
정황
상세 설명
Study Aim:
The purpose of this study is to create an extensively annotated bio-repository platform for hypothesis-driven research that will lead to advancements in the diagnosis, treatment and prevention of diseases common to the population of Indiana. The second phase of this research platform will be created by collecting blood samples from two groups of individuals in the Central Indiana community, one with documented evidence of Diabetes Mellitus Type II(T2D), and a second group of age, gender and ethnicity matched individuals without clinical evidence of Diabetes. Each individual's blood sample will be linked to their clinical, demographic and epidemiological information, gathered both retrospectively and prospectively.
Recruitment:
This study will include 500 individuals with T2D (the T2D Group) and 500 individuals who are age, gender, and ethnicity matched to the T2D Group, but without presentation of clinical evidence of T2D (the Control Group). To reflect the growing representation of Hispanics in Central Indiana, Hispanics will be overly recruited in both groups so that the study population accurately reflects the general population of Central Indiana.
Follow-up:
As this is a prospective, longitudinal study, follow-up of study subjects is intended to include two follow up visit and continue indefinitely, unless, of course, at any time, consent for further follow-up is withdrawn by the subject. Follow-up will include visits at 2 and 5 years post initial contact and continuing access to the subject's medical record to pursue data concerning changes in the subject's health. Subjects may be contacted by telephone, mail or email every twelve months to ask if they wish to continue participation in the study. The 2 and 5 year follow up visits mirror the initial visit.
The collected dataset (made up of the collected blood samples linked to clinical and epidemiological information collected retrospectively and prospectively), will be used in medical research to find genes, or gene products such as RNA or proteins that will help in understanding the causes of disease and will guide the development of new treatments
연구 유형
등록 (예상)
연락처 및 위치
연구 장소
-
-
Indiana
-
Avon, Indiana, 미국
- American Health Network
-
Brownsburg, Indiana, 미국
- Investigator's Research Group
-
Franklin, Indiana, 미국
- American Health Network
-
Greenfield, Indiana, 미국
- American Health Network
-
Indianapolis, Indiana, 미국
- American Health Network
-
Indianapolis, Indiana, 미국
- Krannert Cardiology
-
Indianapolis, Indiana, 미국
- Oral Health Research Institute
-
Indianapolis (Downtown), Indiana, 미국
- IU School of Medicine/CTSI
-
Indianapolis (Spanish speaking), Indiana, 미국
- Alivio Medical Center
-
Indianapolis (Spanish/English speaking), Indiana, 미국
- IU Medical Group
-
Muncie, Indiana, 미국
- American Health Network
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:T2D Group
Study subjects will be recruited for the T2D group based on a history confirmed by the medical record of at least one of the following:
- A fasting blood glucose of greater than or equal to 126 mg/dL on two separate occasions
- A random (non-fasting) blood glucose of greater than or equal to 200 mg/dL on two separate occasions
- A blood glucose of greater than 200 mg/dL at 2 hours during a standard oral glucose tolerance test
- A HgbA1c of greater than or equal to 6.5%
Females who are pregnant will be excluded.
Control Group
Study subjects for the Control Group will have:
- no confirmed history of T2D as defined above
- A fasting blood glucose of 100 mg/dL or less
Medical records will be obtained to ensure subjects meet study inclusion criteria.
-
Exclusion Criteria:Exclusion criteria for both the T2D Group and the Control Group are a known or reported history of:
- Hepatitis B
- Hepatitis C
- AIDS (HIV positive)
- Tuberculosis
- Cancer (including melanoma, but excluding low-malignancy skin cancer)
- Non-autologous bone marrow transplant
- Blood transfusion within 120 days
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
|---|
|
People with Diabetes Mellitus Type II
500 subjects will have T2D
|
|
Healthy
500 persons who do not have T2D, hypertension or hypercholesterol
|
공동 작업자 및 조사자
협력자
수사관
- 수석 연구원: Anantha Shekhar, MD, Indiana University School of Medine/CTSI
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
제2형 당뇨병에 대한 임상 시험
-
Sohag Universitysohag university hospital모병
-
University of Bologna완전한
-
Johns Hopkins University종료됨설인신경통 | 삼차신경통(Burchiel Type I) | 삼차신경통(Burchiel Type II) | 삼차신경병성 통증 | 삼차신경차단 통증 | 복합 부위 통증 증후군(상지 침범 유형 I 및 II) | 경추 탈구로 인한 상지 통증 | 중추 통증 증후군미국
-
Centre Hospitalier Universitaire Dijon종료됨표피암 또는 | 흉부 식도의 선암 또는 | Oesogastric Junction의 샘암종(Siewert Type I 또는 II) | 단계 cT2 N1-3 M0 또는 cT3-T4a N0 또는 N1-3 M0프랑스